Abstract: An image signal indicative of the head pose of a person in a scene, as provided by a camera may be processed by estimating, as a function of the image signal received by the image sensor, the head pose of the person. A view frustum of the person may be generated from the estimated head pose. A visual frustum of attention or VFOA of the person may be generated from the view frustum. From the visual frustum, a predicted movement trajectory of the person or an estimated scene attention map as a function of the visual frustum of attention, preferably by identifying in the attention map at least one object to be controlled may be generated.
Type:
Grant
Filed:
October 10, 2017
Date of Patent:
November 16, 2021
Assignees:
OSRAM GMBH, FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA, UNIVERSITÀ DEGLI STUDI DI VERONA
Inventors:
Marco Cristani, Alessio Del Bue, Michael Eschey, Fabio Galasso, Irtiza Hasan, Herbert Kaestle, Francesco Setti, Theodore Tsesmelis
Abstract: The present invention relates to a chimeric virus particle of potato virus X, said particle having, as a capsid protein, a fusion protein containing a capsid protein and an antigenic determinant of lipocalin, and the use thereof in the in vitro diagnosis of Sjögren's Syndrome using the ELISA method.
Type:
Grant
Filed:
June 3, 2016
Date of Patent:
April 21, 2020
Assignees:
ENEA-AGENZIA NAZIONALE PER LE NUOVE TECNOLOGIE, L'ENERGIA E LO SVILUPPO ECONOMICO SOSTENIBILE, UNIVERSITA' DEGLI STUDI DI VERONA
Inventors:
Chiara Lico, Selene Baschieri, Eugenio Benvenuto, Linda Avesani, Elisa Tinazzi, Elena Bartoloni Bocci, Mario Pezzotti, Claudio Lunardi
Abstract: An isolated monoclonal antibody or fragment thereof binding prostate specific membrane antigen (PSMA) preferably in its native form on the surface of tumour cells. A conjugate of the antibody with an active ingredient and modified forms of the antigen-binding antibody fragment are also provided. The complete antibody and the antigen-recognising fragment thereof are used alone or conjugated for the treatment and the diagnosis of tumours or tissues associated to the tumour overexpressing the PSMA antigen, preferably prostatic neoplastic diseases.
Type:
Grant
Filed:
April 22, 2009
Date of Patent:
April 22, 2014
Assignees:
Universita' degli Studi di Verona, Fondazione IRCCS “Instituto Nazionale dei Tumori”
Inventors:
Marco Colombatti, Giulio Fracasso, Sara Cingarlini, Silvana Canevari, Mariangela Figini
Abstract: The present invention relates to a device for cell culture and analysis, comprising a first containing element, a second containing element sealingly couplable to one another to define a culture chamber and a flexible film housable in said culture chamber and available alternatively on one of said first element or second element. The flexible film can be made of a transparent material selected from the group consisting of polycarbonate, polystyrene and polyethylene. A method for cell analysis is also provided.
Type:
Application
Filed:
February 23, 2011
Publication date:
August 1, 2013
Applicant:
UNIVERSITA' DEGLI STUDI DI VERONA
Inventors:
Marco Chilosi, Mauro Krampera, Mario Ricciardi
Abstract: An isolated monoclonal antibody or fragment thereof binding prostate specific membrane antigen (PSMA) preferably in its native form on the surface of tumour cells. A conjugate of the antibody with an active ingredient and modified forms of the antigen-binding antibody fragment are also provided. The complete antibody and the antigen-recognising fragment thereof are used alone or conjugated for the treatment and the diagnosis of tumours or tissues associated to the tumour overexpressing the PSMA antigen, preferably prostatic neoplastic diseases.
Type:
Application
Filed:
April 22, 2009
Publication date:
February 9, 2012
Applicants:
Fondazione IRCCS "Istituto Nazionale dei Tumori", Universita' degli Studi di Verona
Inventors:
Marco Colombatti, Giulio Fracasso, Sara Cingarlini, Silvana Canevari, Mariangela Figini
Abstract: The present invention concerns a method of expression in plant of glutamic acid decarboxylase (GAD65), particularly a mutated form of human GAD65 (GAD65mut), and expression vectors thereof.
Type:
Application
Filed:
July 24, 2009
Publication date:
November 24, 2011
Applicant:
UNIVERSITA DEGLI STUDI DI VERONA
Inventors:
Linda Avesani, Alberto Falorni, Mario Pezzotti
Abstract: The present invention discloses a peptide having an amino acid sequence comprising an epitope recognized by Igs of patients with active celiac disease and not recognized by Igs of patients on gluten-free diet, antibodies directed against this peptide and methods for diagnosing the celiac disease in a subject, or to check the effect of a therapy or of a diet treatment in a celiac disease affected subject, or to assess the risk of developing celiac disease in a subject vaccinated with a Rotavirus VP7 protein.
Type:
Application
Filed:
April 4, 2007
Publication date:
August 5, 2010
Applicants:
UNIVERSITÀ DEGLI STUDI DI VERONA, ISTITUTO G. GASLINI
Inventors:
Giovanna Zanoni, Claudio Lunardi, Antonio Puccetti